Cytokine- and T-helper-dependent immunity in murine aspergillosis

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 445-454

  Cenci, E ^a   Mencacci, A ^a   Fe D'Ostiani C ^a   Montagnoli, C ^a   Bacci, A ^a   Del Sero, G ^a   Perito, S ^a   Bistoni, F ^a   Romani, L ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4;

ALLERGIC ASTHMA; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL ACTIVATION; FLOW CYTOMETRY; HELPER CELL; IMMUNITY; IMMUNOREGULATION; INFECTION RISK; PRIORITY JOURNAL; REVIEW;

EID: 0032079194     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80768-2     Document Type: Article

References (63)

1. Beyer, J., Schwartz, S., Heineman, V. & Siegert, W. (1994), Strategies in prevention of invasive pulmonary aspergillosis in immunodepressed or neutropenic patients. Antimicrob. Agents Chemother., 38, 911-917.
2. Bernhisel-Broadbent, J., Camargo, E.E., Jaffe, H.S. & Lederman, H.M. (1991), Recombinant human interferon-γ as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J. Infect. Dis., 163, 908-911.
3. Bistoni, F., Cenci, E., Mencacci, A., Schiaffella, E., Mosci, P., Puccetti, P. & Romani, L. (1993), Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J. Infect. Dis., 168, 1449-1457.
4. Bodey, G.P. & Vartivarian, S. (1989), Aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis., 8, 413-437.
5. Cenci, E., Mencacci, A., Spaccapelo, R., Tonnetti, L., Enssle, K.-H., Puccetti, P., Romani, L. & Bistoni, F. (1995), T helper cell type 1 (Th1)-and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th development. J. Infect. Dis., 171, 1279-1288.
6. Cenci, E., Perito, S., Enssle, K.-H., Mosci, P., Latgé, J.-P., Romani, L. & Bistoni, F. (1997), Production of cytokines by T helper cells in mice with invasive aspergillosis. Infect. Immun., 65, 64-70.
7. Clerici, M., Wynn, T.A., Berzofsky, J.A., Blatt, S.P., Hendrix, C.W., Sher, A., Coffman, R.L. & Shearer, G. (1994), Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest., 93, 768-778.
8. Cohen, M.S., Isturiz R.E., Malech H.L., Root, R.K., Wilfert, C.M., Gutman, L. & Bukley, R.H. (1981), Fungal infection in chronic granulomatous disease: the importance of the phagocytes in defense against fungi. Am. J. Med., 71, 59-66.
9. Daynes, R.A., Araneo, B., Dowell, A., Huang, T.A. & Dudley, D. (1990), Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J. Exp. Med., 171, 979-996.
10. Denning, D.W., Follansbee, S.E., Scolaro, M., Norris, S., Edelstein, H. & Stevens, D.A. (1991), Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N. Engl. J. Med., 324, 654-662.
11. de Repentigny, L., Petitbois, S., Boushira, M, Michaliszyn, E., Senechal, S., Gendron, N. & Montplaisir, S. (1993), Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect. Immun., 61, 3791-3802.
12. Dixon, D.M., Polak, A. & Walsh, T.J. (1989), Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect. Immun., 75, 452-456.
13. Djeu, J.Y. (1993), Modulators of immune responses to fungi, in "Fungal infections and immune responses" (Murphy, J.W., Friedman, H., Bendinelli, M.) (pp. 521-532). Plenum Press, New York.
14. Gerson, S.L., Talbot, G.H., Hurwitz, S., Strom, B.L., Lusk, E.J. & Cassileth, P.A. (1984), Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann. Intern. Med., 100, 345-351.
15. Gustafson, T.L., Schaffner, W., Lavely, G.B., Stratton, C.W., Johnson, H.K. & Hutcheson, R. (1983), Invasive aspergillosis in renal transplant recipients : correlation with corticosteroid therapy. J. Infect. Dis., 149, 230-238.
16. Hector, R.F., Yee, E. & Collins, M.S. (1990), Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infect. Immun., 58, 1476-1478.
17. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol., 155, 4790-4797.
18. Huffnagle, G.B., Toews, G.B., Burdick, M.D., Boyd, M.D., McAllister, K.S., McDonald, R.A., Kunkel, S.L. & Strieter, R.M. (1996), Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans infection. J. Immunol., 157, 4529-4536.
19. Kawakami, K., Qifeng, X., Tohyama, M., Qureshi, M.H. & Saito, A. (1996a), Contribution of tumor necrosis factor-alpha (TNF-α) in host defence mechanism against Cryptococcus neoformans. Clin. Exp. Immunol., 106, 468-474.
20. Kawakami, K., Tohyama, M., Xie, Q. & Saito, A. (1996b), Interleukin-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol., 104, 208-214.
21. Keane-Myers, A., Gause, W.C., Linsley, P.S., Chen, S.-J. & Wills-Karp, M. (1997), B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol., 158, 2042-2049.
22. Khoo, S.H. & Denning, D.W. (1994), Invasive aspergillosis in patients with AIDS. J. Infect. Dis., 19 (Suppl. 1), S41-48.
23. + TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol., 94, 215-221.
24. Kullberg, B.-J., Vogels, M.T.E. & van der Meer, J.W.M. (1994), Immunomodulators in bacterial and fungal infections: a review of their therapeutic potential. Clin. Immunother., 1, 43-55.
25. Kurup, V.P., Hari, V., Guo, J., Murali, P.S., Resnick, A., Krishnan, M. & Fink, J.N. (1996), Aspergillus fumigatus peptides differentially express Th1 and Th2 cytokines. Peptides, 183-190.
26. Kurup, V.P., Mauze, S., Choi, S., Seymour, B.W. & Coffman, R.B. (1992), A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J. Immunol., 148, 3783-3788.
27. Lehmann, P.F. & White, L.O. (1975), Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice. Infect. Immun., 12, 987-992.
28. Lehmann, P.F. & White, L.O. (1976), Acquired immunity to Aspergillus fumigatus. Infect. Immun., 13, 1296-1298.
29. Levitz, S., Selsted, M.E., Ganz, T., Lehrer, R.I. & Diamond, R.D. (1986), In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis., 154, 483-489.
30. Lin, J.-Y., Wang, L.-F. & Lin, R.-H. (1996), The association between lung innate immunity and differential airway antigen-specific immune responses. Int. Immunol., 4, 499-507.
31. Mencacci, A., Cenci, E., Del Sero, G., Fè d'Ostiani, C., Mosci, P., Montagnoli, C., Bacci, A., Bistoni, F., Quesniaux, V.F.J., Ryffel, B. & Romani, L. (1998), Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-α double-deficient mice infected with Candida albicans. Int. Immunol., 10, 37-48.
32. Mencacci, A., Cenci, E., Spaccapelo, R., Tonnetti, L., Romani, L., Puccetti, P. & Bistoni, F. (1995), Rationale for cytokine and anti-cytokine therapy of Candida albicans infection. J. Mycol. Med., 5, 25-30.
33. + T-helper-cell responses in mice with low-level Candida albicans infection. Infect. Immun., 64, 4907-4914.
34. Nagai, H., Guo, J., Choi, H. & Kurup, V.P. (1995), Interferon-γ and tumor necrosis factor-cc protect mice from invasive aspergillosis. J. Infect. Dis., 172, 1554-1560.
35. Nawada, R., Amitani, R., Tanaka, E., Niimi, A., Suzuki, K., Murayama, T. & Kuze, F. (1996), Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection. Infect. Immun., 34, 1433-1439.
36. Palmer, L.B., Greenberg, H.E. & Schiff, M. (1991), Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax, 46, 15-20.
37. Pollock, J.D., Williams, D.A., Gifford, M.A., Li, L.L., Du, X., Fisherman, J., Orkin, S.H., Doerschuk, C.M. & Dinauer, M.C. (1995), Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet., 9, 202-209.
38. Puccetti, P., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Enssle, K.-H., Romani, L. & Bistoni, F. (1994), Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis., 169, 1325-1331.
39. Rex, J.H., Bennet, J.E., Gallin, J.I., Malech, H.L., De Carlo, E.S. & Melnick, D.A. (1991), In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J. Infect. Dis., 163, 849-852.
40. Rhodes, J.C. (1993), Aspergillosis, in "Fungal infections and immune responses" (Murphy J.W., Friedman, H., Bendinelli, M.) (pp. 359-377). Plenum Press, New York.
41. Rinaldi, M.G. (1983), Invasive aspergillosis. Rev. Infect. Dis., 5, 1061-1077.
42. Roilides, E., Dimitriadou, A., Kadiltsoglou, I., Sein, T., Karpouzas, J., Pizzo, P.A. & Walsh, T.J. (1997), IL-10 exerts suppressive and enhancing effects on anti-fungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Immunol., 158, 322-329.
43. Roilides, E., Holmes, A., Blake, C., Pizzo, P.A. & Walsh, T.J. (1993a), Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J. Infect. Dis., 167, 905-911.
44. Roilides, E., Holmes, A., Blake, C., Venzon, D., Pizzo, P.A. & Walsh, T.J. (1994), Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J. Infect. Dis., 170, 894-899.
45. Roilides, E., Sein, T., Holmes, A., Blake, C., Pizzo, P.A. & Walsh, T.J. (1995), Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis., 172, 1028-1034.
46. Roilides, E., Uhlig, K., Venzon, D., Pizzo, P.A., Strieter, R.M. & Walsh, T.J. (1993b), Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun., 61, 1185-1193.
47. Roilides, E., Uhlig, K., Venzon, D., Pizzo, P.A. & Walsh, T.J. (1996), Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun., 61, 4870-4877.
48. Romani, L. (1997), The T cell response against fungal infections. Curr. Opin. Immunol., 9, 484-490.
49. Romani, L., Bistoni, F., Mencacci, A., Cenci, E., Spaccapelo, R. & Puccetti, P. (1996a), IL12 in Candida albicans infections. Res. Immunol., 146, 532-538.
50. Romani, L., Bistoni, F. & Puccetti, P. (1997a), Initiation of T helper cell immunity to Candida albicans by IL12: the role of neutrophils. Chem. Immunol., 68, 110-135.
51. + T helper subset selection in mice with candidiasis. J. Immunol., 158, 2356-2362.
52. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Del Sero, G., Nicoletti, I., Trinchieri, G., Bistoni, F. & Puccetti, P. (1997c), Neutrophil production of IL12 and IL10 in candidiasis and efficacy of IL12 therapy in neutropenic mice. J. Immunol., 158, 5349-5356.
53. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol., 150, 925-931.
54. Romani, L., Mencacci, A., Tonnetti, L., Spaccapelo, R., Cenci, E., Puccetti, P., Wolf, S.F. & Bistoni, F. (1994), Interleukin-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol., 153, 5157-5175.
55. Romani, L., Puccetti, P. & Bistoni, F. (1996b), Biological role of helper T-cell subsets in candidiasis. Chem. Immunol., 63, 113-137.
56. Romani, L., Puccetti, P. & Bistoni, F. (1997d), Interleukin-12 in infectious diseases. Clin. Microbiol. Rev., 10, 611-636.
57. Schaffner, A., Douglas, H. & Braude, A. (1982), Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest., 69, 617-631.
58. Spaccapelo, R., Del Sero, G., Mosci, P., Bistoni, F. & Romani, L. (1997), Early T cell unresponsiveness in mice with candidiasis and reversal by IL2. Effect on T helper cell development. J. Immunol., 158, 2294-2302.
59. Subramanian, G., Kazura, J.W., Pearlman, E., Jia, X., Malhotra, I. & King, C.L. (1997), B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 helper cell cytokine expression. J. Immunol., 158, 5914-5920.
60. Tonnetti, L., Spaccapelo, R., Cenci, E., Mencacci, A., Puccetti, P., Coffman, R.L., Bistoni, F. & Romani, L. (1995), Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol., 25, 1559-1565.
61. Tsuyuki, S., Tsuyuki, J., Einsle, K., Kopf, M. & Coyle, A.J. (1997), Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (Th2) immune response and altered airway responsiveness. J. Exp. Med., 185, 1671-1679.
62. Waldorf, A.R., Levitz, S. & Diamond, R.D. (1984), In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis., 150, 752-760.
63. Weinberger, M., Elattar, I., Marshall, D., Steinberg, S.M., Redner, R.L., Young, N.S. & Pizzo, P.A. (1992), Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine, 71, 24-43.